Table 3. Two-year prognosis of NSCLC patients with different expressions of Nanog and Fn14.
Index | Subgroups | Case | Dead (n=25), n (%) | Survival (n=64), n (%) | χ2 | P |
---|---|---|---|---|---|---|
Nanog expression | Positive | 61 | 23 (92.00) | 38 (59.38) | 8.874 | 0.003 |
Negative | 28 | 2 (8.00) | 26 (40.63) | |||
Fn14 expression | Positive | 52 | 20 (80.00) | 32 (50.00) | 6.661 | 0.010 |
Negative | 37 | 5 (20.00) | 32 (50.00) |
NSCLC, non-small cell lung cancer.